Dong Jing, Everitt Jeffrey I, Lau Serrine S, Monks Terrence J
Department of Pharmacology and Toxicology, College of Pharmacy, The University of Arizona Health Sciences Center, Tucson, Arizona 85721, USA.
Toxicol Sci. 2004 Aug;80(2):350-7. doi: 10.1093/toxsci/kfh160. Epub 2004 May 5.
2,3,5-tris-(glutathion-S-yl)-hydroquinone (TGHQ), a metabolite of hydroquinone (HQ), generates reactive oxygen species (ROS) in cultured renal epithelial cells and binds to tissue macromolecules within the rat kidney. The potential mechanisms by which TGHQ induces nephrotoxicity and nephrocarcinogenesis have been examined in cell culture models, but less is known concerning the molecular mechanisms of TGHQ-induced nephrotoxicity in vivo. In LLC-PK1 cells, TGHQ induces phosphorylation of both mitogen-activated protein kinase and histone H3, which likely promotes inappropriate chromatin condensation and mitotic catastrophe. Using the Eker (Tsc-2 mutant) rat as a model, we show by immunohistochemistry that TGHQ (7.5 micromol/kg) selectively induces ERK1/2 phosphorylation within the outer stripe of the outer medulla (OSOM) of the kidney. ERK1/2 phosphorylation is time-dependant, occurring as early as 1 h following treatment, and reaching maximal levels by 4 h. Subsequently, ERK1/2 phosphorylation returns to baseline levels by 24 h post treatment. ERK1/2 phosphorylation was confirmed by western blot analysis of OSOM tissue. Increases in histone H3 phosphorylation occurred subsequent to ERK1/2 phosphorylation (8 h), and reached a peak by 24 h, coincident with histological evidence of tissue necrosis. In contrast to studies in cell culture, neither JNK/SAPK nor p38 MAPK phosphorylation were significantly altered after TGHQ administration in vivo, as evidenced by western blot and immunohistochemical analyses. These data indicate that activation of the ERK1/2 pathway precedes overt cytotoxicity and that the signaling pathways activated by TGHQ in vivo and in vitro differ.
2,3,5-三(谷胱甘肽-S-基)-对苯二酚(TGHQ)是对苯二酚(HQ)的一种代谢产物,可在培养的肾上皮细胞中产生活性氧(ROS),并与大鼠肾脏内的组织大分子结合。在细胞培养模型中已经研究了TGHQ诱导肾毒性和肾致癌作用的潜在机制,但关于TGHQ在体内诱导肾毒性的分子机制了解较少。在LLC-PK1细胞中,TGHQ可诱导丝裂原活化蛋白激酶和组蛋白H3的磷酸化,这可能促进不适当的染色质凝聚和有丝分裂灾难。使用埃克(Tsc-2突变体)大鼠作为模型,我们通过免疫组织化学显示,TGHQ(7.5微摩尔/千克)选择性地诱导肾外髓质外层条纹(OSOM)内的ERK1/2磷酸化。ERK1/2磷酸化是时间依赖性的,早在治疗后1小时就出现,并在4小时达到最高水平。随后,ERK1/2磷酸化在治疗后24小时恢复到基线水平。通过对OSOM组织的蛋白质印迹分析证实了ERK1/2磷酸化。组蛋白H3磷酸化在ERK1/2磷酸化(8小时)之后出现增加,并在24小时达到峰值,与组织坏死的组织学证据一致。与细胞培养研究不同,体内给予TGHQ后,JNK/SAPK和p38 MAPK的磷酸化均未显著改变,蛋白质印迹和免疫组织化学分析证明了这一点。这些数据表明,ERK1/2途径的激活先于明显的细胞毒性,并且TGHQ在体内和体外激活的信号通路不同。